Ipratropium bromide in children with asthma.
Open Access
- 1 January 1982
- Vol. 37 (1) , 72-74
- https://doi.org/10.1136/thx.37.1.72
Abstract
Eighteen children between 6 and 14 years of age with perennial asthma were studied over two four-week treatment periods. Ipratropium bromide, given in addition to their current treatment, was compared with placebo using a double-blind crossover technique. The period of treatment with ipratropium was associated with a significant reduction in symptoms during both day and night and significantly higher morning peak expiratory flow rates.This publication has 12 references indexed in Scilit:
- Ipratropium bromide in acute asthma.BMJ, 1981
- Bronchodilator drugs in childhood asthma.Archives of Disease in Childhood, 1981
- Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies.1979
- SCH 1000 in psychogenic asthma.1979
- CLINICAL-TRIAL OF BRONCHODILATOR EFFECT OF SCH 1000 AEROSOL IN ASTHMATIC-CHILDREN1978
- Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitisRespiratory Medicine, 1978
- Sch 1000: a new anticholinergic bronchodilator.Published by Elsevier ,1975
- The role of the parasymphathetic nervous system in airways disease.1975
- Role of vagus nerves in experimental asthma in allergic dogs.Journal of Applied Physiology, 1972
- Variation of Drug Action on Airway Obstruction in ManThorax, 1964